Shingrix

🇺🇸 United States

FDA Page

Effective Date: Aug 31, 2026
Approval ID: 0280849d-5c78-4a9d-8941-4eab429f6bd8
Products: 0 registered
Version: 24

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX.SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular useInitial U.S. Approval: 2017

Quick Stats

Total Products0

Labelers0

Label Sections0

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.